Iterum Therapeutics plc - stock earnings

ITRM Quarterly earnings

DateEarningsRevenue
2023Q3 -3.9 million USD ? USD
2023Q2 -12.2 million USD ? USD
2023Q1 -9.9 million USD ? USD
2022Q4 -5.1 million USD ? USD
2022Q3 -29.1 million USD ? USD
2022Q2 -6.7 million USD ? USD
2022Q1 -3.5 million USD ? USD
2021Q4 -4.2 million USD ? USD
2021Q3 3.7 million USD ? USD
2021Q2 7.8 million USD ? USD
2021Q1 -98.9 million USD ? USD
2020Q4 -11.2 million USD ? USD
2020Q3 -12.2 million USD ? USD
2020Q2 -12.5 million USD ? USD
2020Q1 -16.1 million USD ? USD
2019Q4 -23.6 million USD ? USD
2019Q3 -31.3 million USD ? USD
2019Q2 -27.6 million USD ? USD
2019Q1 -20.6 million USD 37000 USD
2018Q4 -24.3 million USD 239000 USD
2018Q3 -24.9 million USD 254000 USD
2018Q2 -15.7 million USD 185000 USD
2018Q1 -12.1 million USD 191000 USD
2017Q4 -9.1 million USD 349000 USD
2017Q3 -8.2 million USD 159000 USD
2017Q2 -6.3 million USD ? USD
2017Q1 -5.8 million USD ? USD
2016Q4 -13.5 million USD ? USD

ITRM Yearly earnings

DateEarningsRevenue
2023 -31.1 million USD ? USD
2022 -44.4 million USD ? USD
2021 -91.6 million USD ? USD
2020 -52.0 million USD ? USD
2019 -103.1 million USD 37000 USD
2018 -77.1 million USD 869000 USD
2017 -29.4 million USD 508000 USD
2016 -13.5 million USD ? USD

ITRM

Price: $1.55

52 week price:
0.62
2.50

Earnings Per Share: -2.96 USD

P/E Ratio: -0.65

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 35952

Market Capitalization: 26.0 million

Links: